Dr. Xianjun Sun 孙现军
Chief Physician, Associate Professor
Department of Gastric Surgery, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, minimally invasive, and comprehensive treatment of gastrointestinal tumors. Expertise includes laparoscopic radical gastrectomy, rectal cancer surgery with sphincter preservation, and nutritional support therapy.
Dr. Sun holds an MD and serves as Chief Physician and Associate Professor. Training includes a bachelor's from Binzhou Medical University (1995), master's from Zhengzhou University (1998), and PhD from Shandong University (2003). Joined Shandong Cancer Hospital in 1998; served as Attending Physician (2000) and Associate Chief Physician (2005–present). Published over 20 papers and received awards for research on gastric cancer.
Professional roles
- Youth Member, Tumor Nutrition and Supportive Care Professional Committee, China Anti-Cancer Association
- Member, Gastrointestinal Surgery Group, Shandong Anti-Cancer Association
- Member, Rapid Recovery Group, Shandong Medical Association
- Member, Sub-microsurgery Group, Colorectal Cancer Branch, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Sun Xianjun). Papers usually list the name as Xianjun Sun or Sun X.
Selected publications
6 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Zhongguo Dang Dai Er Ke Za Zhi, 2025 (senior author): [Incidence of small for gestational age infants among singleton live births and analysis of risk factors]. PubMed 41250530
- Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2025 (senior author): [Correlation of LncRNA-PVT1 with Prognosis of Children with Acute Lymphoblastic Leukemia]. PubMed 40017184
- Aging (Albany NY), 2020 (senior author): Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis. PubMed 33318298
- Cancer Cell Int, 2020 (first author): Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer. PubMed 33292253
- Oncol Lett, 2017 (first author): Mastl overexpression is associated with epithelial to mesenchymal transition and predicts a poor clinical outcome in gastric cancer. PubMed 29344164
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion